Skip to main content
< Back
About
About the conference
Organisers & Partners
Registration
App
Podcast
Early Career Researchers
Call for abstracts
Guidelines
Latest updates
Press room
Venue
About the venue
Rooms
Programme
Full programme
Programme outline
Tracks
Speakers
All speakers
Keynote speakers
Side events
Subscribe
days
hours
minutes
seconds
Clinical research/practice
Sessions
Wednesday, 23 October
09:00
e-poster session day 1
09:00
to
18:20
Digital kiosks
e-poster session
10:50
Advances in drug treatment
10:50
to
12:20
Auditorium II
Oral presentation session
Innovative health approaches
10:50
to
12:20
Auditorium III
Oral presentation session
Advancing addiction research: global perspectives and collaborative initiatives
10:50
to
12:20
Auditorium VI
Oral presentation session
Lives at risk: mental health and substance use
10:50
to
12:20
Auditorium VII
Oral presentation session
Treatment of alcohol use disorder
10:50
to
12:20
Room 1.05
Short communication session
Support for recovery
10:50
to
12:20
Room 1.07
Short communication session
Closed session
ECR Programme — Scientific writing
10:50
to
12:20
Room 1.10
Workshop
13:20
Neuroscience and cognition
13:20
to
14:50
Auditorium III
Short communication session
Tobacco, mental health and other substance use
13:20
to
14:50
Auditorium VII
Oral presentation session
Alcohol use disorder: clinical biology and epidemiology
13:20
to
14:50
Room 1.05
Short communication session
Meetings the needs of women who use drugs or alcohol
13:20
to
14:50
Room 1.06
Short communication session
Challenge of measuring use and impact of cannabinoids
13:20
to
14:50
Room 1.07
Oral presentation session
Methods and measurement
13:20
to
14:50
Room 1.08
Short communication session
15:00
Alcohol use from brief intervention to harm reduction
15:00
to
16:30
Auditorium II
Oral presentation session
Infectious diseases in people who inject drugs
15:00
to
16:30
Auditorium IV
Oral presentation session
Substance use and psychosis
15:00
to
16:30
Auditorium VII
Oral presentation session
Assessment of behavioural addictions
15:00
to
16:30
Room 5B
Oral presentation session
Responses to behavioural addictions
15:00
to
16:30
Room 1.05
Short communication session
Quality in addictions work systems
15:00
to
16:30
Room 1.06
Oral presentation session
Problematic gambling and gaming
15:00
to
16:30
Room 1.07
Short communication session
Trauma and addiction - developing skills in the screening of traumatic experiences in addiction care
15:00
to
16:30
Room 1.10
Workshop
16:50
The EUFAS-EAR European Addiction Research Award
16:50
to
18:20
Auditorium I
Major session
Understanding interrelationships: mental health and substance use
16:50
to
18:20
Auditorium VII
Oral presentation session
Psychedelics 1
16:50
to
18:20
Auditorium VIII
Oral presentation session
Opioid treatment 1
16:50
to
18:20
Room 5B
Oral presentation session
Hepatitis C, HIV, and other drug related harms
16:50
to
18:20
Room 1.05
Short communication session
Opioids: trends, use and treatments
16:50
to
18:20
Room 1.06
Short communication session
Thursday, 24 October
10:50
International collaboration to understand and address the co-occurrence of addiction with ADHD and autism spectrum disorders
10:50
to
12:20
Auditorium I
Major session
Opioid treatment 2
10:50
to
12:20
Auditorium III
Oral presentation session
13:20
New opportunities for informing clinical practice and policy development in the area of behavioural addictions
13:20
to
14:50
Auditorium I
Major session
Understanding drug-related deaths
13:20
to
14:50
Auditorium IV
Oral presentation session
Young people, mental health and substance use
13:20
to
14:50
Auditorium VII
Oral presentation session
Understanding harm reduction: economic, social, and health perspectives
13:20
to
14:50
Room 1.05
Short communication session
Writing for 'addiction' journals for early career researchers with DEPP Editors-in-Chief
13:20
to
14:50
Room 1.15
Workshop
15:00
Hepatitis C testing and treatment
15:00
to
16:30
Auditorium IV
Oral presentation session
How can treatment be a better experience?
15:00
to
16:30
Auditorium VII
Oral presentation session
A unique care model for inpatient addictions and tri-morbidity within an acute UK hospital
15:00
to
16:30
Room 5C
Oral presentation session
16:50
How can the voices of people with lived experience, clients and communities impacted by drug use better inform clinical practice, research and the policy agenda?
16:50
to
17:50
Auditorium I
Big debate
Hospital-based treatments
16:50
to
18:20
Room 5B
Oral presentation session
Behavioural addictions, prevention and theory
16:50
to
18:20
Room 1.05
Short communication session
Friday, 25 October
09:00
A comparative discussion on the role, challenges, and opportunities for addiction nurses within Europe
09:00
to
10:30
Room 1.15
Workshop
10:50
Alcohol: interventions and up-to-date technologies
10:50
to
12:20
Auditorium II
Oral presentation session
Psychedelics 2
10:50
to
12:20
Auditorium VI
Oral presentation session
Trauma and substance use
10:50
to
12:20
Auditorium VII
Oral presentation session
Gaming and health
10:50
to
12:20
Room 1.06
Short communication session
Support for the addiction workforce
10:50
to
12:20
Room 1.07
Oral presentation session
13:20
Addressing diverse treatment needs
13:20
to
14:50
Auditorium VI
Oral presentation session
Prevention and addiction in underrepresented groups
13:20
to
14:50
Room 5A
Oral presentation session
Holistic care for mental well-being
13:20
to
14:50
Room 1.05
Short communication session
Research into practice: The implementation and evaluation of alcohol assertive outreach treatment in England
13:20
to
14:50
Room 1.15
Workshop
Presentations
Wednesday, 23 October
09:00
e-poster
The role of dissociative experiences in the link between psychological distress and Problematic Social Network Sites Use
09:00
to
18:20
Digital kiosks
Simon Ghinassi
e-poster
A systematic review of second-hand smoking mass media campaigns (2002-2022)
09:00
to
18:20
Digital kiosks
Carmen Lim
e-poster
Risk of relapse to non-opioids among patients treated with XR-NTX or BP-NLX: A randomized clinical trial
09:00
to
18:20
Digital kiosks
Arild Opheim
e-poster
The lived experience of persons receiving harm reduction services, finding an oasis in the deserted life of drug use
09:00
to
18:20
Digital kiosks
Alexandros Tifas
e-poster
Evaluation of participants' experiences enrolled in a community-based mobile withdrawal management service
09:00
to
18:20
Digital kiosks
Andrew Lodge
e-poster
A feasibility and tolerability study of home-use tDCS in patients with substance use disorders (SUD)
09:00
to
18:20
Digital kiosks
Laia Miquel
e-poster
Effectiveness of the brief intervention for methamphetamine users in Poland
09:00
to
18:20
Digital kiosks
Magdalena Rowicka
e-poster
The prevalence of cannabis use disorders in people who use medicinal cannabis: a systematic review and meta-analysis
09:00
to
18:20
Digital kiosks
Danielle Dawson
e-poster
Is addiction a brain-disease? An overview of the evidence
09:00
to
18:20
Digital kiosks
Chrysanthi Blithikioti
e-poster
Life Entrapment or Trampoline? Understanding life experiences of rejected asylum seekers in Copenhagen’s open drug scene
09:00
to
18:20
Digital kiosks
Arash Setoodeh
e-poster
Tell me who you are, I'll tell you what to do: designing specific interventions for different types of gamers
09:00
to
18:20
Digital kiosks
João Faria
e-poster
Portuguese gym-goers versus Performance-enhancing Substances: What do we know?
09:00
to
18:20
Digital kiosks
Ana Sofia Tavares
e-poster
Offspring of individuals with alcohol use disorders and professionals in addiction counseling: A qualitative study
09:00
to
18:20
Digital kiosks
Fran Calvo
e-poster
Anabolic steroid use and use of other image- and performance-enhancing drugs on the rise – A new substance use disorder
09:00
to
18:20
Digital kiosks
Raphael Magnolini
e-poster
An audit of patient’s Health / Social Care needs referred to a Dual Diagnosis Social Care pathway in Ireland
09:00
to
18:20
Digital kiosks
Aidan Cooney
e-poster
Training Program for Self-management of Substance Addiction Consequences – a Randomized Controlled Trial Pilot Study
09:00
to
18:20
Digital kiosks
Paulo Seabra
e-poster
Are Patients with Schizophrenia Reliably Reporting their Cannabis Use? An African Cross-sectional Study
09:00
to
18:20
Digital kiosks
Said Boujraf
e-poster
Cannabis use and severity of cannabis dependence among Georgian small-scale cannabis growers in 2021
09:00
to
18:20
Digital kiosks
Tamari Mgebrishvili
e-poster
Empowering higher education teachers using tripartite drug awareness training model to support youth well-being
09:00
to
18:20
Digital kiosks
Munir Sewani
e-poster
Exploring the role of gender on treatment outcomes in older adults with alcohol use disorder
09:00
to
18:20
Digital kiosks
Jeppe Tryggedsson
e-poster
Hepatitis C and pharmaceutical multinationals. An approach to the case of Basque Country (Spain) in 2014/2015
09:00
to
18:20
Digital kiosks
Unai Perez de San Roman Landa
e-poster
Exploring Diverse Applications of Multicriteria Decision Analysis in Drug Policy: A Comprehensive Overview.
09:00
to
18:20
Digital kiosks
Nicola Worcman
e-poster
Exploring Cultural Dynamics of Black Asian Ethnic Women in Addiction Recovery
09:00
to
18:20
Digital kiosks
Shinasa Shahid
e-poster
A digital approach to peer led recovery and social connection to address substance use/and or mental health challenges
09:00
to
18:20
Digital kiosks
Susan Barnes
e-poster
Systematic review of recovery of neuropsychological function following abstinence in people with an Alcohol Use Disorder
09:00
to
18:20
Digital kiosks
Anna Powell
e-poster
Evaluation of inpatient conversion from high dose methadone to long-acting injectable buprenorphine (LAIB)
09:00
to
18:20
Digital kiosks
Stuart Fisher
e-poster
The association between psychological distress and alcohol consumption and physical activity
09:00
to
18:20
Digital kiosks
Silvia Eiken Alpers
e-poster
Workforce development and co production as key enablers of successful service delivery.
09:00
to
18:20
Digital kiosks
Martin Blakebrough
e-poster
Degree of smartphone addiction in the university environment
09:00
to
18:20
Digital kiosks
Raul Vernet
e-poster
Personality traits and recovery
09:00
to
18:20
Digital kiosks
Elise Constance Fodstad
e-poster
A narrative review of nurse-led addiction models of care; informing the foundations for international nursing.
09:00
to
18:20
Digital kiosks
Sadie Lavelle Cafferkey
e-poster
Transgender and non-binary people's experiences with alcohol reduction in the UK: A cross-sectional study
09:00
to
18:20
Digital kiosks
Dean Connolly
e-poster
Activities and Experiences of Czech Adolescents in Cyberspace
09:00
to
18:20
Digital kiosks
Martin Dolejš
e-poster
Developing a Toolkit for health care professionals working with Pregnant People who use Drugs in Southern Africa
09:00
to
18:20
Digital kiosks
Julie-Anne Mac Donnell
e-poster
Drug-Facilitated Sexual Assaults involving GHB and GBL in Europe – recent evidence and a need for better monitoring.
09:00
to
18:20
Digital kiosks
María Flores López
e-poster
Systemic biases: Attitudes of correctional staff toward incarcerated people receiving opioid agonist treatment
09:00
to
18:20
Digital kiosks
Joëlle Maguire-L
e-poster
The Development of an Alcohol Strategy for the Northwest Territories, Canada
09:00
to
18:20
Digital kiosks
Bryany Denning
e-poster
Making Hep C treatment more accessible for addictions patients in Belfast
09:00
to
18:20
Digital kiosks
Andrew Teeney
e-poster
Harm Reduction: A Pathway To Community Health in Nigeria
09:00
to
18:20
Digital kiosks
Fatima Abiola Popoola
e-poster
A business of supplying harm reduction : a necessary evil?
09:00
to
18:20
Digital kiosks
François Destombe
e-poster
Association of Alcohol and Tobacco use on COVID-19 outcomes: A Study from East India
09:00
to
18:20
Digital kiosks
e-poster
Alcohol, transitions and communities of belonging within marginalised groups – towards a model of understanding.
09:00
to
18:20
Digital kiosks
Peter Nelson
e-poster
The prevalence of Mental Health Disorders Among Cannabis Users
09:00
to
18:20
Digital kiosks
Ada Hočevar Grom
e-poster
Problematic Mobile Phone Use Related Changes in Topological Organization of Functional Brain Networks
09:00
to
18:20
Digital kiosks
Lichang Yao
e-poster
Comorbid bloodborne diseases among people with opioid use disorders on medication-assisted treatment in Tanzania.
09:00
to
18:20
Digital kiosks
Dorothy Mushi
e-poster
Use of CBD and low-THC products in North Macedonia
09:00
to
18:20
Digital kiosks
Sanja Prosheva
e-poster
Substance Use Treatment for non-speaker of the native language: Implications for migrants and the displaced
09:00
to
18:20
Digital kiosks
Mayar Nawara
e-poster
From intrusive memory to craving in cocaine use disorder – An ecological momentary assessment study
09:00
to
18:20
Digital kiosks
Amelie Zacher
e-poster
Addiction-related dreams: Interpretative Phenomenological Analysis of content and recovery from addiction
09:00
to
18:20
Digital kiosks
Shawn Rutledge
e-poster
Adverse childhood experiences, adult attachment and parenting styles in a population with addictive behaviors
09:00
to
18:20
Digital kiosks
Teodomiro Pires
e-poster
The addiction nursing workforce empowerment - from international perspective to the national implementation and bac
09:00
to
18:20
Digital kiosks
Vendula Pokorná
e-poster
Barriers to Substance Use Treatment as Perceived by Professionals and Arabic Refugees in Germany
09:00
to
18:20
Digital kiosks
Ebtesam Saleh
e-poster
Prevalence of substance use in Austrian prison systems
09:00
to
18:20
Digital kiosks
Andrea Gamper
e-poster
The Moral Improvisation of Harm Reduction in Abstinence Based Drug Policy Amongst Frontline Drug Workers in Hong Kong
09:00
to
18:20
Digital kiosks
Katie Lowe
e-poster
COMPARED RETENTION RATES BETWEEN PATIENTS TREATED WITH BUVIDAL IN FRANCE vs. SUBLINGUAL BUPRENORPHINE (OPALE-2 STUDY)
09:00
to
18:20
Digital kiosks
Alice Deschenau
e-poster
Enhanced Alcohol-Specific Pavlovian-to-Instrumental Transfer in Alcohol Use Disorder
09:00
to
18:20
Digital kiosks
Michael Smolka
e-poster
Implementation of a subject on the care of addiction in the Nursing degree: origin of the need and expectations.
09:00
to
18:20
Digital kiosks
Sheimah El Beijjaji Bouzbita
e-poster
Development of complementary information to drug-related deaths statistics in Slovenia
09:00
to
18:20
Digital kiosks
Mateja Jandl
e-poster
Post-prison support for First Nations men in Australia and Canada
09:00
to
18:20
Digital kiosks
Michael Doyle
e-poster
Framing alcohol policies in non-prohibitionist States: An existentialist dilemma?
09:00
to
18:20
Digital kiosks
Subrata Biswas
e-poster
Cybervictimisation, emotion regulation and family factors in adolescents and young people
09:00
to
18:20
Digital kiosks
e-poster
Resilience and Sense of Coherence as Mediators in the Association between Problematic Mobile Phone Use and Depression
09:00
to
18:20
Digital kiosks
Qi Dai
e-poster
Cannabis use and its link to psychopathological and functional outcomes: Insights from self-reports and hair data
09:00
to
18:20
Digital kiosks
Lydia Johnson-Ferguson
e-poster
People with mental disorders resulting in addiction to alcohol in Poland - legal aspects of medical, social assistance.
09:00
to
18:20
Digital kiosks
Joanna Rajewska de Mezer
e-poster
Integrating Seven Challenges Mastery Counselling and Trauma Informed Care in adolescent substance use interventions.
09:00
to
18:20
Digital kiosks
Daniel Mercieca
e-poster
"Make the difference" - Qualifying professionals working with families with addiction issues
09:00
to
18:20
Digital kiosks
Rebekka Kleinat
e-poster
Electronic cigarettes use among secondary school students in Slovenia
09:00
to
18:20
Digital kiosks
Helena Koprivnikar
e-poster
Implementation of two transdiagnostic psychological interventions for alcohol use: Study protocol, preliminary results
09:00
to
18:20
Digital kiosks
Alba Abanades
e-poster
New criminal legal strategies towards a more effective inmate treatment (The KETHEA PROMITHEAS project)
09:00
to
18:20
Digital kiosks
Apostolos Tsirgoulas
e-poster
Balancing between care and control - staff perception on the introduction of new medication for opioid agonist treatment
09:00
to
18:20
Digital kiosks
Andrea Johansson Capusan
e-poster
ADDIRIS - Addiction and Harm Reduction: a global French-speaking network for online learning
09:00
to
18:20
Digital kiosks
Romain Bach
e-poster
Results of İntegrated Bio-Behavioral surveillance among PWID in Azerbaijan
09:00
to
18:20
Digital kiosks
Gunash Jafarova
e-poster
Burnout and Engagement in Addictive Behaviors and Dependencies HCWs at Portuguese North Region: an epidemiological study
09:00
to
18:20
Digital kiosks
Cátia Coutinho
e-poster
Enrichment of Prevention Methodologies with Self Help/Mutual aid practices: The case of the Centre of Prevention Greece
09:00
to
18:20
Digital kiosks
Sotiris Lainas
e-poster
ComunicAr’te - Communicating through Art in Group Therapy on Addictive Behaviors
09:00
to
18:20
Digital kiosks
Carla Matias
e-poster
Twenty years of integrated treatment of dual disorders in the netherlands: lessons learned
09:00
to
18:20
Digital kiosks
Anneke van Wamel
e-poster
Professional satisfaction and discontent: perspectives of health professionals on Addictive Behaviors and Dependencies
09:00
to
18:20
Digital kiosks
Rita Valinho
e-poster
Evaluation of a UK Bristol capillary blood service for blood-borne virus detection to reach HCV elimination targets
09:00
to
18:20
Digital kiosks
Stephanie Hutchings
e-poster
Prevalence of BBD among PWID in treatment settings in Palestine between 2019-2023
09:00
to
18:20
Digital kiosks
Abeer Habash
e-poster
Social work diagnosis and intervention in a harm reduction service for People Who Use Drugs
09:00
to
18:20
Digital kiosks
Teresa Castro
e-poster
In search of protective factors against burnout in Addictive Behaviors and Dependencies HCWs at Portuguese North Region
09:00
to
18:20
Digital kiosks
Rui Tinoco
e-poster
HCV screening in the treatment centers for people with addictions: lessons learned
09:00
to
18:20
Digital kiosks
Federica Mathis
e-poster
Combination non-medical use of gabapentin and medications for opioid use disorder: A qualitative study
09:00
to
18:20
Digital kiosks
Mance Buttram
e-poster
Online gambling and Loneliness: A State of Knowledge.
09:00
to
18:20
Digital kiosks
Volanirina Rasolofomamonjy
e-poster
A Look at Non-Compliance: Examining Alcohol Industry Marketing Practices in Portugal
09:00
to
18:20
Digital kiosks
Hilson Cunha Filho
e-poster
Forgotten children - losses of children growing up with addicted parents
09:00
to
18:20
Digital kiosks
Szilvia Kassai
e-poster
The effects of syringe service programs on overdose deaths in Tennessee
09:00
to
18:20
Digital kiosks
Ryan Edgerton
e-poster
The association between alexithymia and binge drinking among young people
09:00
to
18:20
Digital kiosks
Pelin Alpay
e-poster
Drug checking via Syringe Vending Machines
09:00
to
18:20
Digital kiosks
Mariam Sherozia
e-poster
Buprenorphine prescription patterns at a tertiary care hospital in northern India: A retrospective chart review
09:00
to
18:20
Digital kiosks
Abhishek Gupta
e-poster
Critical assessment of the role of compulsory treatment of drug use disorders in Germany
09:00
to
18:20
Digital kiosks
Ingo Ilja Michels
e-poster
Negative affectivity, mania, and defense mechanisms in compulsive online buying-shopping disorder
09:00
to
18:20
Digital kiosks
Marina Cosenza
e-poster
Gratitude amidst unease: Interviews with Swedish forensic psychiatric male patients with substance use disorder
09:00
to
18:20
Digital kiosks
Charlotta Svensson
e-poster
Mapping drug users’ spaces of fear in Cologne, Germany
09:00
to
18:20
Digital kiosks
Bo Tackenberg
e-poster
Assessing Food Security and Hunger in Heroin-Assisted Treatment (HAT) Participants: Insights from Norway's HAT Project
09:00
to
18:20
Digital kiosks
Omid Dadras
e-poster
Pilot implementation of a drug overdose reporting tool among Texas harm reduction organizations: A mixed methods study
09:00
to
18:20
Digital kiosks
Jake Samora
e-poster
Working memory in context: the role of alcohol distractors in low to heavy alcohol drinkers
09:00
to
18:20
Digital kiosks
Karis Colyer-Patel
e-poster
Contribution of the workforce to retention of clients in Kombani Medically Assisted Therapy (MAT) in Kwale, Kenya.
09:00
to
18:20
Digital kiosks
Esther Mumo
e-poster
Hospitalizations due to the use of psychoactive substances in Portugal: Impact assessment of the 2008 economic crisis
09:00
to
18:20
Digital kiosks
Joana Silva
e-poster
Exploring the gendered impact on women of the impact of the changes in commissioning in drug and alcohol services.
09:00
to
18:20
Digital kiosks
Victoria Beere
e-poster
Using a digital client segmentation tool among clients with problematic substance use
09:00
to
18:20
Digital kiosks
Ella Plaami
e-poster
Chemsex: An Umbrella Review
09:00
to
18:20
Digital kiosks
Liam Johnstone
e-poster
Mania a Potu: Review of the literature
09:00
to
18:20
Digital kiosks
Ines Valada
e-poster
Challenges and needs of Cologne's open drug scene: insights from a quantitative study on Neumarkt square
09:00
to
18:20
Digital kiosks
Daniel Deimel
e-poster
Medicinal use of non-prescribed cannabis: motives for use, perceived effectiveness and barriers to treatment (MEDUSA)
09:00
to
18:20
Digital kiosks
Lisa Strada
e-poster
Improving the diagnosis and clinical outcomes on drug addict patients through quantitative spectrometer testing.
09:00
to
18:20
Digital kiosks
Teodora Ciolompea
e-poster
DCR in Paris : a constant experiment
09:00
to
18:20
Digital kiosks
Victor Detrez
e-poster
The Intersection of Gambling with Smoking and Alcohol use in Great Britain: A Cross-Sectional Survey in October 2022
09:00
to
18:20
Digital kiosks
Loren Kock
e-poster
Identification and treatment of alcohol use disorder with the 15-method – implementation in psychiatric care
09:00
to
18:20
Digital kiosks
Jennie Sundbye
e-poster
Benefits of a Yoga intervention in portuguese female inmates: preliminary results
09:00
to
18:20
Digital kiosks
Andreia Nisa
e-poster
Long-Term Outcomes of Substance Use Treatment: A 20-Year Follow-Up Study in the Swedish Addiction Treatment System
09:00
to
18:20
Digital kiosks
Tove Sohlberg
e-poster
Doping Prevention among Recreational Athletes and the Role of the Police
09:00
to
18:20
Digital kiosks
Tobias Elgán
e-poster
Mortality Rates and cause-specific mortality in Patients with Substance-Induced Psychosis
09:00
to
18:20
Digital kiosks
Pihla Sassi
e-poster
Psychological Phenotypes in Glambling Disorder: A case study using the Pathway Model
09:00
to
18:20
Digital kiosks
Ana Llorente
e-poster
Trilhos - Evaluation of a developmental prevention program
09:00
to
18:20
Digital kiosks
Inês Abraão
e-poster
Developing practical tools for identifying and supporting treatment-relevant cognitive dys/functions
09:00
to
18:20
Digital kiosks
Maria Bravo Aguilera
e-poster
The potential of eHealth in the treatment of substance use disorders: a perspcitive on digital theraies
09:00
to
18:20
Digital kiosks
André Almeida
e-poster
Scottish stakeholder views on closing the evidence to practice gap in substance use prevention
09:00
to
18:20
Digital kiosks
Tara Shivaji
e-poster
Impact of Adherence to the Opioid Substitution Program on Social Determinants of Health in the West Zone of Porto
09:00
to
18:20
Digital kiosks
Isabel Ponte
e-poster
Inpatient ketamine detoxification, characterization of a treatment-seeking population with complex needs
09:00
to
18:20
Digital kiosks
Osunwale Oni
e-poster
Effects of oxytocin and nicotine addiction on psychosocial stress: an fMRI study
09:00
to
18:20
Digital kiosks
Jiecheng Ren
e-poster
Catalysts for Change: Youth-Driven Insights in Opioid Harm Reduction
09:00
to
18:20
Digital kiosks
Rebeca Calzada
e-poster
"Pictures (and Drugs) at an exibition"
09:00
to
18:20
Digital kiosks
Patrizio Lamonaca
e-poster
Prevention of FASD in Luxembourg – a status report
09:00
to
18:20
Digital kiosks
Jonathan Uselding
e-poster
The role of COVID-19 in sleep quality and cognitive performance in alcohol–dependent patients
09:00
to
18:20
Digital kiosks
Lea Kozina
e-poster
Psychosocial and financial vulnerabilities in loot box purchasing: The mediating role of problem gambling
09:00
to
18:20
Digital kiosks
Anu Sirola
e-poster
Psychological factors associated to problematic gambling in university students from Lima, Perú.
09:00
to
18:20
Digital kiosks
e-poster
OUTCAST REGISTRATION: an archive of imprisoned female drug users' biographies
09:00
to
18:20
Digital kiosks
Ulrike Möntmann
e-poster
Electroencephalographic indices of stages of reward memory and implications for therapeutic memory reconsolidation
09:00
to
18:20
Digital kiosks
Shelan Ofori
e-poster
HIV among people who inject drugs in Stockholm - prevalence, incidence and treatment outcomes
09:00
to
18:20
Digital kiosks
Martin Kåberg
e-poster
A National Survey of Alcohol Care Teams (ACTs) in England: Characteristics of Patients and Components of Care
09:00
to
18:20
Digital kiosks
Philippa Case
e-poster
The role of cartoon humor in the context of addictology efforts for the prevention of alcohol and tobacco use
09:00
to
18:20
Digital kiosks
Linda Kočvarová
e-poster
Exploring dual diagnosis in opioid agonist treatment: A comparative study between the Czech Republic and Norway
09:00
to
18:20
Digital kiosks
Svetlana Skurtveit
e-poster
The Value of Outreach (VALOR): An evaluation of the implementation of alcohol assertive outreach in Greater Manchester
09:00
to
18:20
Digital kiosks
Nikolaos Mylonas
e-poster
Crack cocaine use, street life and migrant population. An Italian observatory by ItaRdd, Cnca, Forum Droghe.
09:00
to
18:20
Digital kiosks
Luca Censi
e-poster
Alcohol, Driving and Crime - Health Care and Justice: An Outreach Intervention
09:00
to
18:20
Digital kiosks
Celestino Cunha
e-poster
Psychosocial Factors Affecting Drug Relapse Among Youth in Pakistan
09:00
to
18:20
Digital kiosks
Abdul Waheed Tabish
e-poster
COVID-19 and earthquakes-related stress, quality of life, mental health, and internet-based addictive behaviour
09:00
to
18:20
Digital kiosks
Tina Peraica
e-poster
Process indicators and outcomes of patients with SUD and Emotional Disorders: Comparison of pre-post COVID-19 pandemic
09:00
to
18:20
Digital kiosks
Oscar M. Lozano
e-poster
An evaluation of “harm reduction” outreach service evaluative research in Macau
09:00
to
18:20
Digital kiosks
Augusto Nogueira
e-poster
Smoking among people who use drugs
09:00
to
18:20
Digital kiosks
Ingeborg Lund
e-poster
Conceptual competence in addiction: integrative contributions from philosophical and theoretical work in psychiatry
09:00
to
18:20
Digital kiosks
Carl Erik Fisher
e-poster
Reitox National Focal Point Drug Monitoring System as a Model for Monitoring Other Addictions in Czechia
09:00
to
18:20
Digital kiosks
Pavla Chomynova
e-poster
Characterising South Africa’s drug markets with people who sell heroin, methamphetamine and cocaine
09:00
to
18:20
Digital kiosks
MJ Stowe
e-poster
Assessing hindering and facilitating factors of help-seeking behaviour in cannabis use: descriptive qualitative study
09:00
to
18:20
Digital kiosks
Laura Väätäinen
e-poster
SCIRe: Substance Consumption Informative Research - testing hair in electronic music festivals
09:00
to
18:20
Digital kiosks
Ana Pego
e-poster
Recreational substance use and cognition in a large cohort of young adults with hair testing: Something is not nothing
09:00
to
18:20
Digital kiosks
Lukas Eggenberger
e-poster
Smartphone addiction and sexual distress: preliminary findings of a study in Portugal
09:00
to
18:20
Digital kiosks
Pedro Campos
e-poster
Neurocognitive Impulsivity in Opiate Users at Different Lengths of Abstinence
09:00
to
18:20
Digital kiosks
Elena Psederska
e-poster
Italian teenagers’ perceived exposure to Digital Alcohol Marketing
09:00
to
18:20
Digital kiosks
Franca Beccaria
e-poster
No alcohol at night – Polish experiences
09:00
to
18:20
Digital kiosks
Marta Zin-Sedek
e-poster
When substance use disorder and eating disorder intersect: an integrated care tool.
09:00
to
18:20
Digital kiosks
Zoya Barbier
e-poster
The role of temperamental self-regulation in predicting treatment outcome in alcohol use disorders
09:00
to
18:20
Digital kiosks
Els Santens
e-poster
Ethical considerations of responsible gambling in metaverse
09:00
to
18:20
Digital kiosks
Susanne Uusitalo
e-poster
Alcohol guidelines in Australia - who knows them?
09:00
to
18:20
Digital kiosks
e-poster
Love Addiction: Trait Impulsivity, Emotional Dysregulation and Attachment Style
09:00
to
18:20
Digital kiosks
Jessica Dineen
e-poster
TREATMENT PROGRAMS FOR CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH MENTAL AND BEHAVIORAL DISORDERS DUE TO PAS USE
09:00
to
18:20
Digital kiosks
Andrej Kastelic
e-poster
Using Functional Near Infrared Spectroscopy to Detect Neurocognitive Differences Across Social Drinking Patterns
09:00
to
18:20
Digital kiosks
Rebecca Kuiper
e-poster
Global trends and Challenges of the Drug Phenomenon in Central Asia
09:00
to
18:20
Digital kiosks
Ernest Robello
e-poster
Online gambling and betting in India and their adverse psychological and social complications: A comprehensive review
09:00
to
18:20
Digital kiosks
Shyam Sundar Kanagarajan
e-poster
Psychosocial Determinants of Cannabis Protective Behavioral Strategies: Perceived Efficacy and Social Norms
09:00
to
18:20
Digital kiosks
Fermin Fernández Calderón
e-poster
Nightlife recreational contexts in Viseu: sexism, sexual violence and potential associations with substance use
09:00
to
18:20
Digital kiosks
Inês Miguel Rodrigues Armelim
e-poster
Impact of fruit smoothie supplementation on psychological distress in patients undergoing opioid agonist therapy
09:00
to
18:20
Digital kiosks
Elaheh Javadi Arjmand
e-poster
Frequency of cannabis and amphetamine use past month in patients on opioid maintenance treatment with buprenorphine
09:00
to
18:20
Digital kiosks
Natasha Simonovska
e-poster
Generative AI to support Harm Reduction
09:00
to
18:20
Digital kiosks
Angus Bancroft
e-poster
30 years of New Psychoactive Substances (NPS) in Europe. A first integrated public health assessment.
09:00
to
18:20
Digital kiosks
Julian Vicente
e-poster
Comparison of HOMA-IR, Tg/Glucose Index and Tg/HDL-C ratio for predicating MetSy in HCV seronegative heroin dependents
09:00
to
18:20
Digital kiosks
Zanina Perevska
e-poster
Rhabdomyolysis in patients following opioid overdose
09:00
to
18:20
Digital kiosks
Aleksandra Babulovska
e-poster
Common mental disorders in prisoners with childhood trauma and substance use; the role of emotion regulation
09:00
to
18:20
Digital kiosks
Faridah Nakoma
e-poster
Program evaluation of a team-based approach addressing mental health and addictions in a Canadian urban centre
09:00
to
18:20
Digital kiosks
Andrew Lodge
e-poster
Public Health addressing illicit drug use and mental health disorders: Interinstitutional Community Intervention Group
09:00
to
18:20
Digital kiosks
Paula Pinto Oliveira
e-poster
Investigating the Relationship Between Stigma and Relapse in IDUs with HIV/AIDS in Pakistan
09:00
to
18:20
Digital kiosks
Jawwad Muhammad Shujaat
e-poster
If you don't know where you're going, why insist on running - A reflection on the lack of data on dropout...
09:00
to
18:20
Digital kiosks
Sofia Freitas
e-poster
Features and correlates of Internet Gaming Disorder in women and men who play video games: a cross-national study
09:00
to
18:20
Digital kiosks
Caitlin McClure-Thomas
e-poster
Challenges in the management of skin and soft tissue infections among people who inject drugs in Athens, Greece.
09:00
to
18:20
Digital kiosks
Apostolia Fragkouli
e-poster
Association between slot machine gambling and debt recovery process-Finnish population-based study with register linkage
09:00
to
18:20
Digital kiosks
Tiina Latvala
e-poster
The recovery of people with addictive behaviours and dependencies: intervention strategies of social workers
09:00
to
18:20
Digital kiosks
Sara Carvalho
e-poster
Self-inflicted cut throat injuries and substance use during COVID-19: An analysis from Nepal
09:00
to
18:20
Digital kiosks
Dipesh Bhattarai
e-poster
Role of Psychiatric Nursing Staff in a Newly Founded Ward for Treatment of Adolescents Facing Addiction
09:00
to
18:20
Digital kiosks
Aleš Zajc
e-poster
Long-term Effects of the STAD-model: A Multi-Component Responsible Beverage Service Intervention
09:00
to
18:20
Digital kiosks
Johanna Gripenberg
e-poster
Therapeutic Effects of Ayahuasca: The Psychological Processes Involved in the Relief of Depression and Grief.
09:00
to
18:20
Digital kiosks
Mafalda Pinto Ribeiro
e-poster
Threat or opportunity: End-user perspectives on digital interventions for treatment of cannabis use
09:00
to
18:20
Digital kiosks
Jasmin Lostedt
e-poster
Gender violence experienced by women who use drugs
09:00
to
18:20
Digital kiosks
Ana Isabel Ibar-Fañanás
e-poster
The role of coping in the association between cannabis use disorder and mental health; a one-year prospective study
09:00
to
18:20
Digital kiosks
Nora de Bode
e-poster
Analysis of the satisfaction survey results of users of the Mobile Drug Consumption Room Program in Lisbon
09:00
to
18:20
Digital kiosks
Adriana Almeida
e-poster
Community led networking and advocacy for the elimination of discrimination of women who use drugs in Europe
09:00
to
18:20
Digital kiosks
Ligia Parodi
e-poster
Experiences of female substance users with trauma-sensitive yoga as complementary support in addiction treatment
09:00
to
18:20
Digital kiosks
Julie Schamp
e-poster
Efficacy of a digital intervention to reduce or stop cannabis use : study protocol for a randomized controlled trial
09:00
to
18:20
Digital kiosks
Emmanuel Lahaie
e-poster
Self-rated health among patients in opioid agonist therapy
09:00
to
18:20
Digital kiosks
Jan Tore Daltveit
e-poster
Impact of first cardiovascular event versus consecutive episodes on tobacco and alcohol use: a comprehensive analysis
09:00
to
18:20
Digital kiosks
Maria Teresa Pons
e-poster
Navigating cannabis access in zurich: A road safety perspective from early observations of the 'Züri Can' study
09:00
to
18:20
Digital kiosks
Patricia Dürler
e-poster
The impact of the tobacco law on hospitalizations due to the abusive consumption of psychoactive substances
09:00
to
18:20
Digital kiosks
Filipe Pinto
e-poster
Anxiety, Depression, Stress, and Self-Harm in relation to Gaming Disorder: A Longitudinal Study of Czech Adolescents
09:00
to
18:20
Digital kiosks
Jaroslava Suchá
e-poster
Complicated Alcohol Withdrawal Syndrome: retrospective study of an inpatient alcohol treatment unit
09:00
to
18:20
Digital kiosks
Ines Pereira
e-poster
Addiction, a volitional disorder.
09:00
to
18:20
Digital kiosks
Nicolas Figueired
e-poster
Oniomania: a case study according to the differential diagnosis
09:00
to
18:20
Digital kiosks
Sofia Nunes
e-poster
Advancing Addiction Interventions: Porto's Comprehensive Approach in the Municipal Health Plan
09:00
to
18:20
Digital kiosks
Paula Pinto Oliveira
e-poster
"Supersavers" manages large proportion of opioid overdoses – 5-year follow-up of a regional naloxone program, Sweden
09:00
to
18:20
Digital kiosks
Katja Troberg
e-poster
Mapping psychedelic retreats and other practices in the EU
09:00
to
18:20
Digital kiosks
Tereza Černíková
e-poster
Oniomania: what is known today?
09:00
to
18:20
Digital kiosks
Margarida Duarte
e-poster
Ageing in the context of the Opioid Maintenance Treatment in Portugal: Impact of public health policies on ageing users
09:00
to
18:20
Digital kiosks
Lara Queiroz Sampaio
e-poster
Recreational Cannabis and Social Media Use: A Correlational Cross-Sectional Study
09:00
to
18:20
Digital kiosks
Roni Deli-Houssein
e-poster
Psilocin inhibits CYP450 metabolism of isoforms 2A6 and 3A4
09:00
to
18:20
Digital kiosks
Andreia Machado Brito-da-Costa
e-poster
"How generational transmissions can shape life?" Evaluation of a genogram group therapy for people with ACoA syndrome
09:00
to
18:20
Digital kiosks
Katarzyna Iwanicka
e-poster
Piloting a strategy to prevent and manage alcohol-related problems in underage population at risk in health services
09:00
to
18:20
Digital kiosks
Carla Filipa Bruguera
e-poster
Burden of disease due to drug use disorders in the European Union: analysis of 1990-2019 trends and patterns
09:00
to
18:20
Digital kiosks
Vera Pinheiro
e-poster
Willingness and Contextual Considerations for Supervised Consumption Sites among People Who Inject Drugs in Stockholm
09:00
to
18:20
Digital kiosks
Elin Holmén
e-poster
LGBTQIA2S+ perspectives on problem gambling among their peers: Preliminary results of semi-structured interviews
09:00
to
18:20
Digital kiosks
Anne-Marie Auger
e-poster
DUDIT-E Brazilian Adaptation and TrIE-AD Application Development: A Intervention Approach for Young Drug Users
09:00
to
18:20
Digital kiosks
Richard Alecsander Reichert
e-poster
Riscos & Desafios Program: the students’ voice
09:00
to
18:20
Digital kiosks
Gizela Rendo
e-poster
THE ROLE OF WORK IN THE TREATMENT OF INDIVIDUALS RECOVERING FROM ADDICTION
09:00
to
18:20
Digital kiosks
Farshad moshiri
e-poster
Changes in self-reported alcohol use post absolute alcohol sales bans: the case of Botswana during COVID pandemic.
09:00
to
18:20
Digital kiosks
J. Maphisa Maphisa
e-poster
Understanding Overdose Risk Perception in People who use Drugs - A Systematic Review
09:00
to
18:20
Digital kiosks
Kerry B.D. Campbell
e-poster
Effects of a universal school based alcohol prevention intervention
09:00
to
18:20
Digital kiosks
Bert Hauspie
e-poster
Risky online behavior in relation to social support, depression and anxiety in Czech adolescents
09:00
to
18:20
Digital kiosks
Terezie Babilonová
e-poster
Veterinary Drugs as Toxic Adulterating Substances in the Street Drug Supply
09:00
to
18:20
Digital kiosks
Barry Logan
e-poster
IN VITRO INHIBITORY POTENTIAL OF CLASSIC HALLUCINOGENS LSD, 5-MEO-DMT AND MESCALINE OVER CYTOCHROME P450 ENZYMES
09:00
to
18:20
Digital kiosks
Mariana Carvalho
e-poster
Working Towards Health and Wellness: The Infinite Pathways of Recovery
09:00
to
18:20
Digital kiosks
Meghann Perry
e-poster
Can we prevent the misuse of prescription stimulants? : a case report
09:00
to
18:20
Digital kiosks
Ivana Todorić Laidlaw
e-poster
Risks and challenges of scaling up the intervention – an analysis of the program dissemination process
09:00
to
18:20
Digital kiosks
Carla Rocha
e-poster
Lived/Living experiences: the potential for integrative collaborations
09:00
to
18:20
Digital kiosks
Mary Beth Zeni
e-poster
Applying foresight research for drug policy: Lessons from the DRUG-PREP project
09:00
to
18:20
Digital kiosks
Bert Hauspie
e-poster
Estimation of prevalence (and patterns) of cannabis use from various data sources
09:00
to
18:20
Digital kiosks
Darja Lavtar
e-poster
Providing psychiatric services for hepatitis C virus patients with substance use disorders
09:00
to
18:20
Digital kiosks
Anna Gorodetsky
e-poster
Acute and Chronic Effects of Cannabis on the Neural Correlates of Working Memory in Adolescents versus Adults
09:00
to
18:20
Digital kiosks
Sorcha Hamilton
e-poster
The future of smoking is female: Barriers for women to quit. A review.
09:00
to
18:20
Digital kiosks
e-poster
High and repeated use of MDPV induce chronic psychosis in patients with no psychiatric history
09:00
to
18:20
Digital kiosks
Andrea Anastasi
e-poster
A Prospective Study: Patterns and Trends in Opioid Use and Treatment with Focus on Older Populations
09:00
to
18:20
Digital kiosks
Jo-Hanna Ivers
e-poster
Suicidal Behaviors and Alcohol Dependence: A Comprehensive Literature Review
09:00
to
18:20
Digital kiosks
Marco Mota Oliveira
e-poster
Assessing progress towards viral hepatitis B and C elimination in prison settings in the European region
09:00
to
18:20
Digital kiosks
Riccardo Pisetta
e-poster
Experiences with Xylazine among Residential Treatment Patients
09:00
to
18:20
Digital kiosks
Courtney Nordeck
e-poster
Stigma and substance use disorders: a scoping review of patient and health care professionals’ attitudes.
09:00
to
18:20
Digital kiosks
Ashlyn Schwartz
e-poster
The necessary adaptation of a public Therapeutic Community to new needs of the treatment process.
09:00
to
18:20
Digital kiosks
Rita Fazenda Vieira
e-poster
Cannabis use and withdrawal and escalation to psychiatric intensive care
09:00
to
18:20
Digital kiosks
Edward Chesney
e-poster
“To smoke feels gender”: A Photovoice Study of Cannabis Use Among Transgender and Non-Binary Youth
09:00
to
18:20
Digital kiosks
Christian Barborini
e-poster
The effect of Cue-induced Retrieval and Reconsolidation with Episodic Foresight on craving in opioid users receiving MMT
09:00
to
18:20
Digital kiosks
Parnian Rafei
e-poster
Cannabis legalization in Germany: Update on an ongoing process
09:00
to
18:20
Digital kiosks
e-poster
Sleep dysregulation in alcohol use disorders. An exploratory study with a gender perspective.
09:00
to
18:20
Digital kiosks
Ana Llorente
e-poster
Voices of the unhoused from Santa Fe, New Mexico: health status, substance use, and community harm reduction views
09:00
to
18:20
Digital kiosks
Laura Brown
e-poster
The Last Decade in Turkish Addiction Research: A Thesis-Based Analysis
09:00
to
18:20
Digital kiosks
Belgin Varol
e-poster
Fentanyl among adolescent in Poland - the scale of the phenomenon and preventive actions
09:00
to
18:20
Digital kiosks
Ewelina Silecka-Marek
e-poster
The comparison and analysis of blood antioxidant levels in alcohol and drug addiction
09:00
to
18:20
Digital kiosks
Nelly Sapojnikova
e-poster
Stigma by association among alcohol and other drug and harm reduction workers: Implications for workplace outcomes
09:00
to
18:20
Digital kiosks
Theresa Caruana
e-poster
Cortical thickness and brain aging in individuals engaging in unhealthy alcohol use
09:00
to
18:20
Digital kiosks
Marco Hermesdorf
e-poster
Alcohol use across trials of psychological interventions for bipolar: A systematic review and meta-analysis
09:00
to
18:20
Digital kiosks
Lauren Halsall
e-poster
Optimizing Overdose Response in the Emergency Department: New challenges and initiatives in Scotland
09:00
to
18:20
Digital kiosks
Lisa Schölin
e-poster
Hybrid skills transfer of the unplugged prevention programme in a French high school abroad (Lisbon, Portugal 2023 2024)
09:00
to
18:20
Digital kiosks
Marion Fal
e-poster
Applied health research in alcohol-related liver disease: a rapid qualitative inquiry with healthcare providers
09:00
to
18:20
Digital kiosks
Sofia Hemrage
e-poster
Caring with Care: VITAE’s integrative and therapeutic model towards socially vulnerable individuals
09:00
to
18:20
Digital kiosks
Brenda Sousa da Silva
e-poster
Addictive Behaviours Workforce development: from global to European higher education programs
09:00
to
18:20
Digital kiosks
Olatz López Fernández
e-poster
Substance Use Among College Students in India: Necessity for Intervention
09:00
to
18:20
Digital kiosks
Anju Dhawan
e-poster
Meaning and Self-control in Alcohol Use and Internalizing Symptoms: Causal Insights from (Non)clinical Populations
09:00
to
18:20
Digital kiosks
Marcel Näther
e-poster
Italian Validation of Assessment of Recovery Capital Scale in Clinical Population with Alcohol and Drugs Use Disorder
09:00
to
18:20
Digital kiosks
Teo Vignoli
e-poster
Building Capacity for Social Return on Investment Analysis of Supervised Consumption Services in Saskatoon SK, Canada
09:00
to
18:20
Digital kiosks
Barbara Fornssler
e-poster
Intervention methods for the psychological problems faced by the wives of individuals with substance use disorders.
09:00
to
18:20
Digital kiosks
Ranasinghe Mudiyanselage Sanjeewani Senevirathne
e-poster
Systematic analysis of Interventions for Opioid Use Disorder Among Adolescents
09:00
to
18:20
Digital kiosks
Joye Anestis
e-poster
Perceptions of alcohol-related problems among social workers and their clients
09:00
to
18:20
Digital kiosks
e-poster
The prevalence, risk and protective factors of the co-morbidity of neurodiversity and substance use.
09:00
to
18:20
Digital kiosks
Catherine Comiskey
e-poster
SCHEMATIC FUNCTIONING AND EMOTIONAL REGULATION IN ALCOHOL DEPENDENCE: A CLINICAL AND NON-CLINICAL SAMPLE COMPARISON
09:00
to
18:20
Digital kiosks
Ana Catarina Nunes da Silva
e-poster
Unmasking addictions: exploring the role of attributional styles
09:00
to
18:20
Digital kiosks
Ana Tavares
e-poster
Prevention Matters: Towards a National Model of Prevention (within the National Programme on Illicit Drugs 2023 - 2030)
09:00
to
18:20
Digital kiosks
Mateja Markl
e-poster
Assessing Therapeutic Alliance: A Pilot Study Measuring Therapeutic Alliance and It's Impact on Patient Outcomes
09:00
to
18:20
Digital kiosks
Siobhan Morse
e-poster
The Impact of psychotherapy on Comorbid Borderline Personality Disorder and Substance Use Disorder: A Systematic Review
09:00
to
18:20
Digital kiosks
Manuel Jesús Ruiz Muñoz
e-poster
The Autonomic Craving Signature: a biomarker of craving for personalized addiction treatment
09:00
to
18:20
Digital kiosks
Marc Auriacombe
e-poster
Enhancing HIV Self-Testing Uptake through Syringe Vending Machines: A Case Study in Tbilisi, Georgia
09:00
to
18:20
Digital kiosks
Irma Kirtadze
e-poster
Therapy of alcohol-dependent women serving prison sentences in Polish prisons
09:00
to
18:20
Digital kiosks
Hanna Karaszewska
e-poster
Image and performance enhancing drugs among gym and fitness visitors in Slovenia – preliminary results
09:00
to
18:20
Digital kiosks
Julijana Zucchiati Godina
e-poster
Assessing the prevalence of problem gambling among the Slovenian population
09:00
to
18:20
Digital kiosks
Špela Selak
e-poster
Investigating the relationship between defense styles and treatment motivation of Turkish males with alcohol use problem
09:00
to
18:20
Digital kiosks
Fatmatüz Zehra Pehlivan
e-poster
Packaging of disposable vaping products and e-liquids in England, Canada, and the United States: a content analysis
09:00
to
18:20
Digital kiosks
Matilda Nottage
e-poster
The effect of smoking cessation interventions on socioeconomic inequalities in smoking: A Cochrane systematic review
09:00
to
18:20
Digital kiosks
Annika Theodoulou
e-poster
Drug-Related Deaths following Bariatric surgery: Case Series Report
09:00
to
18:20
Digital kiosks
Eman Mshari
e-poster
Adherence to Opioid Use Disorder treatment with an extended-release weekly and monthly injectable buprenorphine
09:00
to
18:20
Digital kiosks
Michael Frost
e-poster
Case Series: Prospective Study on the Efficacy of Pregabalin in Managing Opioid Withdrawal Syndrome
09:00
to
18:20
Digital kiosks
Sofia Golbreich
e-poster
Is Integrating Online Stop Smoking Support to Existing Online Talking Therapy Support Feasible?
09:00
to
18:20
Digital kiosks
Pamela Jacobsen
e-poster
Is Decriminalising drugs enough? Navigating alternatives to prohibitionism
09:00
to
18:20
Digital kiosks
Jorge Quintas
e-poster
Leveraging AI to supercharge the training and support of extended workforce in addiction services
09:00
to
18:20
Digital kiosks
Christina Todorova
e-poster
Shaping a model for Incentivised Drug Free Living wings in prison
09:00
to
18:20
Digital kiosks
e-poster
Trust in healthcare providers for information about cannabis
09:00
to
18:20
Digital kiosks
Meredith Meacham
e-poster
Spanish version of the Bergen Social Media Addiction Scale (BSMAS): validity, reliability and measurement invariance
09:00
to
18:20
Digital kiosks
Conchita Sisi Martin
e-poster
Impact of the Decriminalization on Drug Use Experiences and Related Risks among People Who Use Drugs in British Columbia
09:00
to
18:20
Digital kiosks
Cayley Russell
e-poster
Opiate-Dependent Service Users knowledge and attitudes towards Supervised Injecting Facilities
09:00
to
18:20
Digital kiosks
Annika Gibbons
10:50
Short communication
Efficacy of Cognitive vs. Mindfulness Targeted Hypnotic Suggestion on Working Memory and Relapse in Alcohol Treatment
10:50
to
12:20
Room 1.05
Timo Kvamme
Short communication
Controlled alcohol drinking rooms. Madrid's experience.
10:50
to
12:20
Room 1.05
Sonsoles Gutiérrez-Cáceres
Short communication
Implicit Social Attunement & Alcohol Use: The Effect of Peer Feedback on Willingness to Drink in Social Settings
10:50
to
12:20
Room 1.05
Emese Kroon
Short communication
TeleHealth Resources for IndiVidualizEd Goals (THRIVE) in Alcohol Recovery Study: Initial Findings
10:50
to
12:20
Room 1.05
Katie Witkiewitz
Oral presentation
NIDA International Program Research Update
10:50
to
12:20
Auditorium VI
Tom Clarke
Oral presentation
Lisdexamfetamine in the treatment of methamphetamine dependence, a randomised controlled trial
10:50
to
12:20
Auditorium II
Nadine Ezard
Short communication
A randomised controlled trial assessing the effectiveness of a smartphone app intervention for alcohol-dependent adults
10:50
to
12:20
Room 1.05
Josefine Östh
Oral presentation
Understanding the research capacity of Australian alcohol and other drug services
10:50
to
12:20
Auditorium VI
Robert Stirling
Oral presentation
Treatment of benzodiazepine withdrawal through taper dosing is most successful when it lasts less than 6 months.
10:50
to
12:20
Auditorium II
Alert Drishti
Oral presentation
Managing Benzodiazepine Dependence and High-Risk Use with Opiates: A feasibility study of a Co-produced Intervention
10:50
to
12:20
Auditorium II
Catriona Matheson
Short communication
Autobiographical reasoning: a process involved in the clinical evolution of individuals with alcohol use disorder?
10:50
to
12:20
Room 1.05
Clara De Groote
Oral presentation
World Addiction Medicine Reports: International Society of Addiction Medicine Global Expert Network Global Surveys
10:50
to
12:20
Auditorium VI
Short communication
PREDICTORS OF TREATMENT COMPLETION AND DISCONTINUATION IN GROUP TREATMENT OF PATIENTS WITH AUD: RESULTS FROM A NORWEGIAN MULTI-SITE PREDICTOR STUDY
10:50
to
12:20
Room 1.05
Kristoffer Høiland
Oral presentation
Report from LX24 side event - Strengthening networks and sharing innovation in practices on research and surveillance in the drugs field
10:50
to
12:20
Auditorium VI
Vickna Kasinather,
Charles Parry
Oral presentation
The effectiveness of naloxone in reversing opioid overdose: The European naloxone outcome research study (NalPORS)
10:50
to
12:20
Auditorium II
Nicola Metrebian
Oral presentation
Suicide-related service presentations following residential treatment for substance use disorders: a data linkage study
10:50
to
12:20
Auditorium VII
Calvert Tisdale
Oral presentation
Bipolar disorder and severe poisoning due to medicines or illicit substances
10:50
to
12:20
Auditorium VII
Aleksi Hamina
Oral presentation
The impact of severe mental illness on treatment retention and all-cause mortality of people in opioid agonist treatment
10:50
to
12:20
Auditorium VII
Nicola Jones
Oral presentation
Hazardous substance use and mental health among refugees in shared accommodations – a mixed-methods study
10:50
to
12:20
Auditorium VII
Miriam Lorenz
Oral presentation
EUDA research model
10:50
to
12:20
Auditorium VI
Maria Moreira
Oral presentation
Non-invasive brain stimulation restores METH-induced behavior disorder via prefrontal cortex-ventral striatum circuit
10:50
to
12:20
Auditorium II
Oral presentation
Brief alcohol intervention in the breast screening setting? A hybrid type-II effectiveness-implementation trial
10:50
to
12:20
Auditorium III
Oral presentation
User experiences of a digital intervention among individuals on opioid use disorder treatment in Kenya
10:50
to
12:20
Auditorium III
Sarah Kanana Kiburi
Oral presentation
Cultural safety and telecare. A systematic scoping review and sector survey
10:50
to
12:20
Auditorium III
Rodrigo Ramalho
Oral presentation
An App-Based Prevention Programme targeting Substance Use, Gambling, and Digital Media Use: Usage and Effectiveness
10:50
to
12:20
Auditorium III
Oral presentation
The role of physical activity in preventing relapse: the perception of participants
10:50
to
12:20
Auditorium III
Florence Piché
Short communication
The role of specialist substance use and addiction treatment in building recovery capital
10:50
to
12:20
Room 1.07
Florian De Meyer
Short communication
Recovery does not stop at discharge: A qualitative evaluation of Alcohol Recovery Navigators in North East England.
10:50
to
12:20
Room 1.07
Emma-Joy Holland
Short communication
Exploring Personal Strengths and Resources in Long-Term Substance Use Disorder Recovery: Insights from Lived Experience
10:50
to
12:20
Room 1.07
Myriam Beaulieu
Short communication
The effect of Individual Placement and Support on employment outcomes for individuals with substance use disorders
10:50
to
12:20
Room 1.07
Eline Borger Rognli
Short communication
Understanding the process of drug addiction recovery through learning from lived experience
10:50
to
12:20
Room 1.07
Thomas Martinelli
Short communication
Emotional dysregulation as a predictor of cocaine severity and withdrawal symptoms
10:50
to
12:20
Room 1.07
Alba Palazón-Llecha
Short communication
A systematic review of the nuances of attachment, bonding and parenting for mothers in addiction recovery
10:50
to
12:20
Room 1.07
Louise McCulloch
Short communication
Embodied Storytelling: An Accessible Approach to Re-storying in the Recovery Process
10:50
to
12:20
Room 1.07
Meghann Perry
Short communication
Successful alcohol and cannabis counselling in Germany: What is the difference between medical and legal referrals?
10:50
to
12:20
Room 1.05
Moritz Rosenkranz
Oral presentation
Drug Consumption Rooms in Europe. Operational characteristics, capacities, services and its associated factors.
10:50
to
12:20
Auditorium III
Joana Moura
13:20
Short communication
A qualitative exploration of the Alcohol Harm Paradox among different socioeconomic groups in Australia
13:20
to
14:50
Room 1.05
Klaudia Kepa
Short communication
A spatial examination of liquor licence density and the level of disadvantage of schools in Ireland
13:20
to
14:50
Room 1.05
Anne Doyle
Short communication
What’s the risk, does underaged drinking influence employment outcomes for young adults?
13:20
to
14:50
Room 1.05
Nicholas Taylor
Short communication
Alcohol and youth neurodevelopment: a systematic review of longitudinal brain imaging studies
13:20
to
14:50
Room 1.05
Dhatsayini Rattambige
Short communication
Medications for alcohol use disorder in alcohol-related cirrhosis
13:20
to
14:50
Room 1.05
Hugo López Pelayo
Short communication
B-Phosphatidylethanol sampling in primary health care to detect harmful alcohol use – perceptions among physicians
13:20
to
14:50
Room 1.05
Åsa Steensland
Short communication
Phosphatidylethanol as an outcome measure in treatment aimed at controlled drinking
13:20
to
14:50
Room 1.05
Joar Guterstam
Oral presentation
The challenge of cannabis quantification: from theory to practice
13:20
to
14:50
Room 1.07
Cláudia Sousa-Reis
Oral presentation
Reporting THC level in cannabis products: a global multidisciplinary expert consensus
13:20
to
14:50
Room 1.07
Oral presentation
intEgrating Smoking Cessation treatment As part of usual Psychological care (ESCAPE): a pilot and feasibility trial
13:20
to
14:50
Auditorium VII
Oral presentation
Pharmacology of generic ban-evading synthetic cannabinoid receptor agonists: are new compounds spicing up the market?
13:20
to
14:50
Room 1.07
Marie Deventer
Oral presentation
Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the CAMS-2020 study
13:20
to
14:50
Room 1.07
Short communication
NK1 antagonism modulates negative emotional processing in abstinent opioid dependent individuals and healthy controls
13:20
to
14:50
Auditorium III
Lexi Hand
Short communication
Easy to reach, hard to research: cognitive function and substance use characteristics of people with severe drug use.
13:20
to
14:50
Auditorium III
Nina Auestad
Oral presentation
Psychological distress, tobacco smoking and alcohol use: a population survey in Great Britain
13:20
to
14:50
Auditorium VII
Erikas Simonavičius
Oral presentation
Smokers’ careers and mental health: overlapping perspectives on cannabis and tobacco use
13:20
to
14:50
Auditorium VII
Joana Sisternas-Tusell
Short communication
Attention and reward related brain activity in cannabis users: A registered report of a longitudinal study
13:20
to
14:50
Auditorium III
Inês Macedo
Oral presentation
From intra-familial childhood adversities to tobacco use: Assessing the mediating role of bullying among Tunisian youth
13:20
to
14:50
Auditorium VII
Short communication
Neural Correlates of Addiction: A Resting-State Meta-Analysis of Substance Use Disorders and Behavioral Addictions
13:20
to
14:50
Auditorium III
Marc Ritter
Short communication
The bodily parallel: Bridging Gaps in Current Theories of Addiction and Interoception
13:20
to
14:50
Auditorium III
Mateo Leganes-Fonteneau
Short communication
Social Cognition in people with substance use disorders
13:20
to
14:50
Auditorium III
Sónia Rodrigues
Short communication
Does lisdexamfetamine maintenance help or hinder cognitive function in people with current methamphetamine dependence?
13:20
to
14:50
Auditorium III
Raimondo Bruno
Short communication
Phosphatidylethanol as a screening tool for alcohol consumption during pregnancy
13:20
to
14:50
Room 1.06
Margareeta Häkkinen
Short communication
Digital Invisibility: Presence of Substance Use Disorder Treatment Programs for Women in the Caribbean
13:20
to
14:50
Room 1.06
Rocio Suarez Ordoñez
Short communication
Utilization of pharmacological treatment for alcohol use disorder in pregnancy in the total Swedish population
13:20
to
14:50
Room 1.06
Sara Wallhed Finn
Short communication
The important role of social connectedness in the alcohol use of women aged 50 to 62 years.
13:20
to
14:50
Room 1.06
Grainne Clarke
Oral presentation
How Are African Countries Leveraging Health Communication For Tobacco Use Prevention With Young People: A Scoping Review
13:20
to
14:50
Auditorium VII
Charity Aienobe-Asekharen
Short communication
Barriers and Enablers in Disclosing Substance Use by Pregnant Women in Australian prisons
13:20
to
14:50
Room 1.06
So Bi Kim
Short communication
Prevalence and trends of ethanol and drugs among arrested drivers in Norway in the period 2013-2023
13:20
to
14:50
Room 1.08
Ragnhild Jamt
Short communication
Tuning In for Chemistry: Setting up a multi-instrument mobile drug-checking lab at a 7-day psychedelic music festival
13:20
to
14:50
Room 1.08
Daniel Martins
Oral presentation
Changes in cannabis potency and cannabis-related harms: A 22-year ecological study in Denmark
13:20
to
14:50
Room 1.07
Kristine Rømer Thomsen
Short communication
In favor or against the codependency concept: A narrative review of arguments in scientific literature
13:20
to
14:50
Room 1.08
Alexis Beaulieu-Thibodeau
Short communication
The relationship between cannabis and tobacco use - a systematic review and meta-analysis
13:20
to
14:50
Room 1.08
Tesfa Mekonen
Short communication
Towards 2029: Learnings from unified Australian involvement in drug-related United Nations fora
13:20
to
14:50
Room 1.08
Short communication
Cognitive impairment as a predictor of long-term psychological distress in patients with polysubstance use disorders
13:20
to
14:50
Auditorium III
Jens Hetland
Short communication
Ethyl glucuronide in maternal hair to objectively assess alcohol consumption in the three trimesters of pregnancy
13:20
to
14:50
Room 1.05
Katarzyna Okulicz-Kozaryn
Short communication
Alcohol prevention: a review using Topic Modelling
13:20
to
14:50
Room 1.08
Nina Harth
Oral presentation
Levels of toxicants among people who vape, smoke, dual use, or do neither among people with and without psychosis.
13:20
to
14:50
Auditorium VII
Eve Taylor
Short communication
Cannabis and mental health in Germany: a baseline estimation pre legalization
13:20
to
14:50
Room 1.08
Eva-Maria Krowartz
Short communication
Evaluation of heroin-assisted treatment in Norway: Protocol for a mixed methods study
13:20
to
14:50
Room 1.08
Lars Henrik Myklebust
15:00
Oral presentation
Increased hepatitis C and HIV incidence among people who inject drugs in Montreal, Canada, 2011-2023
15:00
to
16:30
Auditorium IV
Sarah Larney
Oral presentation
Alcohol Mis(Use) among Migrants, Asylum-seekers and Refugees: state-of-the-art
15:00
to
16:30
Auditorium II
Maria Pires Cameira
Oral presentation
Harm reduction interventions and Indigenous peoples: The first Managed Alcohol Program in Montreal
15:00
to
16:30
Auditorium II
Rossio Motta-Ochoa
Oral presentation
Predictors of outcome in individuals with alcohol use disorder and a treatment goal of controlled drinking
15:00
to
16:30
Auditorium II
Anders Hammarberg
Oral presentation
Crafting the international standard: Establishing and implementing core outcome measures for alcohol brief interventions
15:00
to
16:30
Auditorium II
Gillian W. Shorter
Oral presentation
Evaluating and comparing health quality for addiction treatment in the Lazio region, Italy
15:00
to
16:30
Room 1.06
Antonella Camposeragna
Oral presentation
Considering the prevention workforce: a study on practitioner needs when recommending substance use interventions
15:00
to
16:30
Room 1.06
Natalie Blackburn
Oral presentation
Decentralized consultation for infectious diseases with at-risk populations: preliminary results
15:00
to
16:30
Auditorium IV
Paulo Caldeira
Oral presentation
Associations of alcohol consumption with long-term mortality of ART-naïve persons seeking HIV care.
15:00
to
16:30
Auditorium IV
Daniel Fuster
Oral presentation
“They kicked me out of hospital twice”: barriers and facilitators accessing care with an injecting-related infection
15:00
to
16:30
Auditorium IV
Samantha Colledge-Frisby
Oral presentation
Planning and Monitoring drug and alcohol treatment in Denmark. The MapPlan project.
15:00
to
16:30
Room 1.06
Mads Uffe Pedersen
Oral presentation
HIV Risk behaviors of People who Inject drugs in 12 districts of Bangladesh: Evidence from a Rapid Situation Assessment
15:00
to
16:30
Auditorium IV
Oral presentation
How do you make it work? A pragmatic framework for the Sustained Uptake of Service Innovations (SUSI).
15:00
to
16:30
Room 1.06
Catherine Foley
Short communication
Outcomes from the first womens’ residential treatment centre for gambling harm in the UK
15:00
to
16:30
Room 1.05
Oral presentation
The Problematic Behaviour Scale (PBS-10): psychometric characteristics and cut-offs using Swiss national survey data
15:00
to
16:30
Room 5B
Sebastian Mader
Short communication
A pilot program using Tabletop Role-Playing Games to reduce social anxiety and addiction symptoms in online gamers
15:00
to
16:30
Room 1.05
Joël Billieux
Oral presentation
The Gaming Disorder Identification Test (GADIT) - A screening tool for Gaming Disorder based on ICD-11
15:00
to
16:30
Room 5B
Gary Chan
Short communication
Efficacy assessment of the universal problem-gambling prevention program "What at stake?"
15:00
to
16:30
Room 1.05
Daniel Lloret-Irles
Oral presentation
Screening Measures on Internet Use Disorders in Children and Adolescents - A Delphi Study
15:00
to
16:30
Room 5B
Hans-Juergen Rumpf
Short communication
Toward a classification of technology design features promoting potentially addictive online behaviors
15:00
to
16:30
Room 1.05
Maèva Flayelle
Oral presentation
Instruments assessing Gaming Disorder in children and adolescents – A systematic review of psychometric properties
15:00
to
16:30
Room 5B
Samantha Schlossarek
Short communication
The “Me and others” prevention program: impact evaluation in a sample of Portuguese adolescents
15:00
to
16:30
Room 1.05
Joana Alexandre
Short communication
A mindfulness-based intervention for craving reduction in gambling and video gaming disorder: A case study.
15:00
to
16:30
Room 1.05
Francisco José Rivero Ramón
Short communication
The long and winding road to gambling disorder treatment
15:00
to
16:30
Room 1.05
David Hodgins
Oral presentation
Antipsychotics and relapse risk in persons with first-episode psychosis and co-occurring cannabis use disorder
15:00
to
16:30
Auditorium VII
Heidi Taipale
Oral presentation
“Into a whirlwind”: Navigating psychosis and anti-psychotic treatment among youth entrenched in an urban drug scene
15:00
to
16:30
Auditorium VII
Trevor Goodyear
Oral presentation
Cannabinoid Use Experience among inpatients with psychotic symptoms – A Cross-Sectional study in a Portuguese Hospital
15:00
to
16:30
Auditorium VII
Carolina Afonso Romano
Oral presentation
Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis
15:00
to
16:30
Auditorium VII
Antti Mustonen
Short communication
What increases the risk of problem gambling in adolescents? Findings from the Greek arm of the ESPAD study
15:00
to
16:30
Room 1.07
Alexandra Primeti
Short communication
Financial hardship and gambling severity: a population-based study in Finland
15:00
to
16:30
Room 1.07
Tanja Grönroos
Short communication
Harmful types of gambling: Changes and emerging trends in longitudinal helpline data
15:00
to
16:30
Room 1.07
Håkan Wall
Short communication
Accessibility, local socioeconomic disadvantage and expenditure on electronic gambling machines
15:00
to
16:30
Room 1.07
Jani Selin
Short communication
Extended hours of video game play and negative physical symptoms and pain
15:00
to
16:30
Room 1.07
Janni Leung
Short communication
Prevention is key: A case of a gambling prevention program among Portuguese high-school students
15:00
to
16:30
Room 1.07
Short communication
Religiosity and gambling - moderating role of reflective thinking: A Polish-Georgian Study
15:00
to
16:30
Room 1.07
Rafał Bartczuk
Short communication
The influence of CBT based treatment and therapeutical contract guidelines on a problem gambler abstinence treatment
15:00
to
16:30
Room 1.05
Pedro Hubert
Short communication
Online Gambling Companies’ Interpretation of Duty of Care and its Implication for Responsibilisation of Gambling Related Harm
15:00
to
16:30
Room 1.07
Maria Persson
16:50
Keynote presentation
The increase of 100% alcohol-attributable mortality in the EU during COVID-19 – implications for the health care system
16:50
to
18:20
Auditorium I
Jürgen Rehm
Keynote presentation
The EAR-EUFAS European Addiction Research Award 2024 - presentation of the award and the awardee
16:50
to
18:20
Auditorium I
Karen Ersche,
Colin Drummond
Keynote presentation
Andreas Heinz’ award lecture: Learning mechanisms in addictive disorders
16:50
to
18:20
Auditorium I
Andreas Heinz
Short communication
STTBI risk reduction with OAT among people with prescription-type opioid use disorder
16:50
to
18:20
Room 1.05
M. Eugenia Socias
Short communication
Are Australian pharmacists willing and prepared to offer Hepatitis C services? Findings from a representative sample
16:50
to
18:20
Room 1.05
Louisa Picco
Short communication
Looking under rocks: Skin infections in people who use drugs: a mixed-methods investigation in Wales
16:50
to
18:20
Room 1.05
Michelle Hughes
Short communication
HCV antibody and RNA testing combined with nursing and peer-based outreach to enhance HCV testing and treatment among vulnerable groups
16:50
to
18:20
Room 1.05
Solange Mendes Ascensão
Short communication
Prevalence and microelimination of Hepatitic C in intravenous drug users - improving linkage to care
16:50
to
18:20
Room 1.05
Eva-Carina Heier
Short communication
Improving the model of care pathway for HCV between the drug care centres and their referral hospitals in Catalonia.
16:50
to
18:20
Room 1.05
Elena Torrell -Pedreira
Oral presentation
The relationship between self-reported childhood maltreatment and mental health in substance use disorders
16:50
to
18:20
Auditorium VII
Aleksander Hagen Erga
Oral presentation
Effects of cannabis use timing and formulation on sleep among young adults who report high-intensity alcohol use
16:50
to
18:20
Auditorium VII
Elizabeth R. Aston
Oral presentation
Examining Associations Between Alcohol and Cannabis Simultaneous and Concurrent Co-Use and Mental Health Outcomes
16:50
to
18:20
Auditorium VII
Bradley Conner
Oral presentation
Route-Dependent Subjective Effects of Medical Heroin in HAT: Implications for Treatment Trajectories
16:50
to
18:20
Room 5B
Silvana De Pirro
Oral presentation
AN IMPLEMENTATION SCIENCE EVALUATION OF SCOTLAND’S FIRST HEROIN ASSISTED TREATMENT (HAT) FACILITY
16:50
to
18:20
Room 5B
Andrew McAuley
Oral presentation
Reduced health care utilization after entering opioid agonist treatment; change in mental and somatic health domains
16:50
to
18:20
Room 5B
Thomas Clausen
Oral presentation
Achieving universal health coverage of opioid agonist treatment in Norway: a cost-utility analysis
16:50
to
18:20
Room 5B
Prayash Chaudhary
Oral presentation
Self-therapeutic use of psilocybin, MDMA and ketamine among Dutch nightlife attendees.
16:50
to
18:20
Auditorium VIII
Frederiek Schutten
Oral presentation
Medical use of psychedelic substances: EUDA's monitoring of key developments
16:50
to
18:20
Auditorium VIII
Alexander Söderholm
Oral presentation
Navigating Psychedelic Therapy for Addiction: Past, Present, and Future
16:50
to
18:20
Auditorium VIII
Short communication
Oxycodone and Morphine use in hospitals and primary healthcare in Norway 2010-2021
16:50
to
18:20
Room 1.06
Eirik Haarr
Short communication
Global utilization trends for weekly/monthly injectable buprenorphine (CAM2038) in the treatment of Opioid Use Disorder
16:50
to
18:20
Room 1.06
Michael Frost
Short communication
Trends in the detection and co-detection of drugs in a population attending opioid agonist treatment: 2010 to 2020
16:50
to
18:20
Room 1.06
Gráinne Cousins
Short communication
Being Seen and Heard: Exploring the Relational Dimension of Heroin Assisted Treatment in Norway.
16:50
to
18:20
Room 1.06
Vegard Haukland
Short communication
Death after residential treatment for opioid use disorder among people using fentanyl
16:50
to
18:20
Room 1.06
Jan Gryczynski
Oral presentation
The U.S. Psilocybin Landscape: Policy Evolution and Nationally Representative Insights
16:50
to
18:20
Auditorium VIII
Beau Kilmer
Short communication
Mortality among long-term prescription opioid users
16:50
to
18:20
Room 1.06
Gabriela Rolová
Short communication
Adão e Eva II Project – HIV, Hepatitis and other STI’s prevention and screening among hard-to-reach populations
16:50
to
18:20
Room 1.05
Paulo Anjos
Oral presentation
Comorbidity of substance use disorders and other mental health disorders: towards a common European approach
16:50
to
18:20
Auditorium VII
Marta Torrens
Thursday, 24 October
10:50
Keynote presentation
International Collaboration on ADHD and Substance Abuse (ICASA): Mission, studies, results, and plans
10:50
to
12:20
Auditorium I
Wim van der Brink
Keynote presentation
International Collaboration on ADHD and Substance Abuse: Consensus statements
10:50
to
12:20
Auditorium I
Cleo Crunelle
Keynote presentation
Identifying the most important research, policy and practice questions for substance use, problematic alcohol use and behavioural addictions in autism (SABA-A): A priority setting partnership
10:50
to
12:20
Auditorium I
Julia Sinclair
Oral presentation
Opioid disorder treatment outcomes — the OPTIMUS international consensus on evidence-based and patient-centred care
10:50
to
12:20
Auditorium III
Lucas Wiessing
Oral presentation
Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022
10:50
to
12:20
Auditorium III
Michael Farrell
Oral presentation
Health-related quality of life trajectories of patients in heroin-assisted treatment
10:50
to
12:20
Auditorium III
Francesca Melis
Oral presentation
Examining declining opioid agonist treatment rates during pregnancy in Ontario, Canada
10:50
to
12:20
Auditorium III
Oral presentation
A Global Perspective on Treatment Service Provision for Opioid Use Disorders
10:50
to
12:20
Auditorium III
Arash Khojasteh Zonoozi
Oral presentation
Did the relaxation in supervised opioid agonist treatment during Covid-19 increase methadone-related deaths in England?
10:50
to
12:20
Auditorium III
John Marsden
13:20
Keynote presentation
Policy approaches in behavioral addictions: past experiences and possible Future Directions
13:20
to
14:50
Auditorium I
Orsolya Király
Keynote presentation
Recovery from Behavioral Addictions: Concepts, Unique Challenges and Issues
13:20
to
14:50
Auditorium I
Belle Gavriel-Fried
Oral presentation
Dynamic associations between anxiety and alcohol use from early adolescence to young adulthood.
13:20
to
14:50
Auditorium VII
Margot Peeters
Keynote presentation
Treatment of Behavioural Addictions: Where are we now?
13:20
to
14:50
Auditorium I
Klaus Wölfling
Short communication
Treatment pathways and transitions of young adults during opioid maintenance treatment
13:20
to
14:50
Room 1.05
Sanna Iivonen
Short communication
Effect of integrated smoking cessation treatment on smoking intensity among persons who receive opioid agonist treatment
13:20
to
14:50
Room 1.05
Karl Trygve Druckrey-Fiskaaen
Short communication
Experience of marginalized PWID with harm reduction interventions in the context of primary healthcare.
13:20
to
14:50
Room 1.05
Short communication
Homeless people and mental health: an observational study in an Emergency Shelter in Lisbon
13:20
to
14:50
Room 1.05
Gonçalo Henriques
Oral presentation
Drug-related deaths among housed and homeless individuals in the UK and the USA
13:20
to
14:50
Auditorium IV
Emmert Roberts
Short communication
An economic evaluation of Catalonia’s Needle Exchange Programme (NEP). Cost-Benefit analysis
13:20
to
14:50
Room 1.05
Asier Narbarte Arzuaga
Oral presentation
Drug-related mortality associated with gabapentinoid/Z-drug co-prescribing among opioid-agonist treatment recipients
13:20
to
14:50
Auditorium IV
Megan Glancy
Short communication
Prescribed safer supply in British Columbia: de-prescribing and impacts on substance use
13:20
to
14:50
Room 1.05
Oral presentation
Policy Responses to Drug-Related Deaths: The power of numbers?
13:20
to
14:50
Auditorium IV
Lena Eriksson
Oral presentation
High body mass index is prevalent in people with opioid use disorder in Northern England and increases risk of death
13:20
to
14:50
Auditorium IV
Caroline Copeland
Short communication
A multisite implementation trial of collaborative care for Opioid Dependence: 3-month outcomes from the EPIC-MATOD trial
13:20
to
14:50
Room 1.05
Suzanne Nielsen
Short communication
A socio-ecological systematic review of harm reduction interventions addressing the U.S. opioid overdose epidemic
13:20
to
14:50
Room 1.05
Katie McCormick
Oral presentation
Contextualising experiences of comorbid mental ill-health and substance use among trans and gender diverse young people
13:20
to
14:50
Auditorium VII
Oral presentation
Substance use variation among LGBTQ+ youth: stress, resilience and ecosystemic intervention
13:20
to
14:50
Auditorium VII
Julie-Christine Cotton
Oral presentation
A randomized controlled trial of support programs for parents of treatment-refusing substance using young adults
13:20
to
14:50
Auditorium VII
Ola Siljeholm
Oral presentation
Understanding substance use and affective symptoms in late adolescents in an urban context: A network approach
13:20
to
14:50
Auditorium VII
Helle Larsen
Short communication
Multi Parameter Estimation of Prevalence modelling: methods to estimate the prevalence of opioid dependence in Scotland
13:20
to
14:50
Room 1.05
Andreas Markoulidakis
15:00
Oral presentation
Background and establishment of the Addiction Clinical Care Suite (ACCS): a comprehensive, multi-disciplinary inpatient addiction service in London
15:00
to
16:30
Room 5C
Shantelle Quashie
Oral presentation
The Addiction Clinical Care Suite (ACCS): service outline and 2 year outcome data
15:00
to
16:30
Room 5C
John Archer
Oral presentation
ACCS complexity of care provision
15:00
to
16:30
Room 5C
Jacob Krzanowski
Oral presentation
Psychosocial Care
15:00
to
16:30
Room 5C
Paul O'Brien
Oral presentation
Pilot HCV Birth Cohort Screening in UK Primary Care using a postal oral fluid home testing kit: the HEPCAPP StudyPP STUDY
15:00
to
16:30
Auditorium IV
Matt Hickman
Oral presentation
Modelling the impact of scaling up of HCV case finding and treatment for people who inject drugs in England
15:00
to
16:30
Auditorium IV
Zoe Ward
Oral presentation
A national program to scale-up decentralized HCV point-of-care testing and treatment in Australia
15:00
to
16:30
Auditorium IV
Jason Grebely
Oral presentation
HCV Community-led monitoring: from consultation to effective policy contributions
15:00
to
16:30
Auditorium IV
Lynn Jefferys,
Joana Canedo
Oral presentation
Service user and Carer perspective on Treatment for Co-Occurring Mental Health and Substance Use Problems (RECO Study)
15:00
to
16:30
Auditorium VII
Elizabeth Hughes
Oral presentation
Treatment satisfaction among patients in opioid agonist treatment: a multicenter study
15:00
to
16:30
Auditorium VII
Oral presentation
The use of patient-reported outcomes in residential alcohol & drug services in Belgium: findings from the OMER-BE study
15:00
to
16:30
Auditorium VII
Amine Zerrouk
Oral presentation
Functional recovery among patients with dual disorders: the role of stigma
15:00
to
16:30
Auditorium VII
Nusa Segrec
Oral presentation
Dropout from addiction treatment: predictors, patient profiles, outcomes, and recommendations to improve care.
15:00
to
16:30
Auditorium VII
Marie-Josee Fleury
16:50
Discussion
How can the voices of people with lived experience, clients and communities impacted by drug use better inform clinical practice, research and the policy agenda?
16:50
to
17:50
Auditorium I
Tony Duffin,
Luís Mendão,
Joanne Neale,
Elizabeth (Elza) Berk,
Judy Chang
Short communication
Could we talk about exercise addiction in the context of ultra-distance running?
16:50
to
18:20
Room 1.05
Abel Nogueira López
Short communication
Craving across addictions: Application of the CASBAS in non-problematic, risky, and pathological usage groups
16:50
to
18:20
Room 1.05
Stephanie Antons
Short communication
The relationship between gambling and suicides or suicidality: Qualitative literature review
16:50
to
18:20
Room 1.05
Janne Nikkinen
Short communication
Conceptualising the commercial determinants of gambling-related harm, self-harm and suicide
16:50
to
18:20
Room 1.05
Angela Rintoul
Short communication
Transdiagnostic compulsivity traits in problematic use of the internet (PUI) symptoms: A network analytic approach
16:50
to
18:20
Room 1.05
Short communication
Compulsive Sexual Behaviour Disorder and its Psychopathological Correlates: Data from the International Sex Survey (ISS)
16:50
to
18:20
Room 1.05
Ilaria De Luca
Short communication
Is 'exercise addiction' a problematic behavior indeed? The importance of controlling for predictors
16:50
to
18:20
Room 1.05
Attila Szabo
Oral presentation
Non-Fatal Overdose: A Decade-Long Analysis of Inner-City Hospitals and Nationwide Trends Across Ireland (2011-2021)
16:50
to
18:20
Room 5B
Jo-Hanna Ivers
Oral presentation
Data collection on acute drug toxicity using the Euro-DEN plus model in countries bordering the European Union
16:50
to
18:20
Room 5B
Thomas Néfau
Oral presentation
Inpatient admissions in people with opioid dependence: a portuguese population-based observational retrospective study
16:50
to
18:20
Room 5B
José Miguel Paupério
Oral presentation
Acute drug-toxicity presentations involving polydrug use to Euro-DEN Plus sentinel hospitals in Europe from 2014 to 2022
16:50
to
18:20
Room 5B
Peter Heudtlass
Short communication
Social network models to understand the relationships between protective and risk factors in problematic gambling
16:50
to
18:20
Room 1.05
Chiara Andrà
Friday, 25 October
10:50
Oral presentation
My way up: efficacy of a gamified webapp for the improvement of treatment retention in patients with ALD
10:50
to
12:20
Auditorium II
Oral presentation
Effectiveness of Machine Learning Based Adjustments to an eHealth Intervention Targeting at Risk Alcohol Use
10:50
to
12:20
Auditorium II
Matthijs Blankers
Oral presentation
Identification and treatment of AUD with the 15-method – Evaluating effectiveness of the method in Danish primary care
10:50
to
12:20
Auditorium II
Anette Søgaard Nielsen
Oral presentation
Smartphone-Delivered Cognitive Bias Modification for Reducing Harmful Drinking amongst middle – older age adults
10:50
to
12:20
Auditorium II
Victoria Manning
Oral presentation
Vicarious Trauma Among Nurses Working in Addiction Services and the Role of Leadership: A European Mixed Methods Study
10:50
to
12:20
Room 1.07
K. Nicki Annunziata
Oral presentation
The Mental Health Challenges Faced by Harm Reduction Staff
10:50
to
12:20
Room 1.07
Laoise Darragh
Oral presentation
Identifying and preventing burnout in the drug and alcohol workforce
10:50
to
12:20
Room 1.07
Oral presentation
Overdoses in Healthcare Workers: A thematic framework analysis of coroner reports
10:50
to
12:20
Room 1.07
Thikra Algahtani
Short communication
#What´sUP_TuDecides – Healthy Influencer of Internet and Gaming Use
10:50
to
12:20
Room 1.06
Carla Andrade
Short communication
Exploring characteristics of videogame use and mental health in expert and casual female gamers
10:50
to
12:20
Room 1.06
Roxanne Hébert-Ratté
Short communication
Media portrayal of sports betting in Canada before and after Bill C-218
10:50
to
12:20
Room 1.06
Luke Clark
Short communication
The Football Fans and Betting Project – Findings from an early intervention for male sports bettors
10:50
to
12:20
Room 1.06
Blair Biggar
Short communication
The comparison of gaming and gambling in relation to decision-making behavior and implicit associations
10:50
to
12:20
Room 1.06
Nanne Dominick
Short communication
Video gaming: observational, genetic, and causal associations with cognition and health
10:50
to
12:20
Room 1.06
Joelle Pasman
Short communication
First results from a cohort of young eSports participants in schools
10:50
to
12:20
Room 1.06
Oral presentation
Qualitative examination of coping motives, microaggressions, and psychological distress among bisexual+ women survivors
10:50
to
12:20
Auditorium VII
Gabriela Lopez
Oral presentation
Posttraumatic stress disorder treatment in patients with co- substance use disorders: a randomized clinical trial
10:50
to
12:20
Auditorium VII
Marleen de Waal
Oral presentation
Implementing trauma-focused integrated treatment for women with PTSD and substance use disorder in Australia
10:50
to
12:20
Auditorium VII
Shalini Arunogiri
Oral presentation
Psychedelic therapy in the treatment of addiction: the past, present and future
10:50
to
12:20
Auditorium VI
Rayyan Zafar
Oral presentation
The old kid in the block: Unpacking signals of increased availability and use of ketamine
10:50
to
12:20
Auditorium VI
Rita Jorge
Oral presentation
Ketamine use in a large global sample: characteristics, patterns of use and emergency medical treatment.
10:50
to
12:20
Auditorium VI
Oral presentation
The feasibility, meaningfulness, and preliminary effect of trauma focused treatment for drug use disorders in Denmark
10:50
to
12:20
Auditorium VII
Sidsel Karsberg
Short communication
Video gaming in older adults: Resilience to impairment
10:50
to
12:20
Room 1.06
Daniel Stjepanovic
Short communication
Sex differences in gaming disorder: Implication for a comprehensive treatment in lower-middle income country
10:50
to
12:20
Room 1.06
Kristiana Siste
Oral presentation
Current perspectives on the research and medical use of psychedelic drugs for alcohol addiction treatment
10:50
to
12:20
Auditorium VI
Anton Gomez-Escolar
Oral presentation
Behind the frontlines: Exploring mental well-being and burnout among harm reduction workers
10:50
to
12:20
Room 1.07
Katie McCormick
Oral presentation
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review
10:50
to
12:20
Auditorium VI
Emmert Roberts
13:20
Oral presentation
Issues of transport, driving safety & intoxication for opioid agonist treatment clients in New South Wales, Australia
13:20
to
14:50
Auditorium VI
Daniel Winter
Oral presentation
Physical conditions and associated health service utilization among individuals with substance-related disorders
13:20
to
14:50
Auditorium VI
Christophe Huỳnh
Oral presentation
The effect of substance use disorders on vaccine uptake, acceptance, and adherence: a global systematic review
13:20
to
14:50
Auditorium VI
Eva Maria Havelka
Oral presentation
Out of treatment drug and alcohol users in England: ‘Unmet Treatment Need’?
13:20
to
14:50
Auditorium VI
Charlie Lloyd
Oral presentation
Addressing Alcohol-Related Risks among Individuals with Disabilities in Sports: A Swiss Perspective
13:20
to
14:50
Room 5A
Nikolai Kiselev
Oral presentation
The multidimensional needs and integrated service utilization patterns of youth using non-medical prescription opioids
13:20
to
14:50
Room 5A
Kirsten Marchand
Oral presentation
Culturally safe addiction services: An integrated circle of care for homeless Indigenous peoples in Montréal, Canada
13:20
to
14:50
Room 5A
Jessica Neicun
Oral presentation
Substance Use, Well-being, and Spiking among LGBTIQ+ and Non-LGBTIQ+ Nightlife Patrons: A Cross-Sectional Survey
13:20
to
14:50
Room 5A
Ruben van Beek
Short communication
Exercise program in opioid agonist therapy and effect on psychological distress: Preliminary findings from a rct
13:20
to
14:50
Room 1.05
Short communication
Mitigating Trauma and Problematic Drug Use with a Focus on Empathy – Insights from Metzineres
13:20
to
14:50
Room 1.05
Aura Roig Forteza
Short communication
The impact of dietary patterns on addiction vulnerability
13:20
to
14:50
Room 1.05
Short communication
Intervention variability predicts social rehabilitation indicators at discharge in long-term residential treatment.
13:20
to
14:50
Room 1.05
Katia Barreto
Short communication
Breaking Chains: Interventions for Reducing Internalized Stigma and Boosting Self-Esteem in Substance Use Behaviors
13:20
to
14:50
Room 1.05
Andreia Florido
Short communication
Addressing the needs of individuals with concurrent disorders: a complexity arising
13:20
to
14:50
Room 1.05
karine Gaudreault
Short communication
Towards a better connection
13:20
to
14:50
Room 1.05
Chico Taguba
Oral presentation
Assessing and managing cognitive deficit as a comorbidity in drug addiction
13:20
to
14:50
Auditorium VI
Short communication
Towards improved access for people with a migration background to harm reduction and health services.
13:20
to
14:50
Room 1.05
Ancella Voets
Short communication
Trauma-Informed care approach with people who use drugs
13:20
to
14:50
Room 1.05
Joana Pires